Abstract
A new series of 3-aryl-5-(pyridin-3-yl)-1-thiocarbamoyl-2-pyrazoline derivatives (4a-j) were prepared by the reaction of azachalcons 3a-j with thiosemicarbazide in ethanolic sodium hydroxide. The structure of synthesized compounds were confirmed by 1H NMR and Mass spectral data. Their antibacterial activities against Escherichia coli (CTP 7624), Staphylococcus aureus (ATCC 6538), Staphylococcus epidermidis (ATCC 12229), Pseudomonas aeruginosa (ATCC 9027), Bacillus subtilis (ATCC 1156) and Micrococcus luteus (ATCC 9341) were investigated. Antifungal activity of compounds against Candida albicans and Candida globrata were found to be inactive. Compounds 4a-j were also evaluated for antituberculosis activity against Mycobacterium tuberculosis H 37 Rv (ATCC 27294) in BACTEC 12B using a broth microdilution assay and Microplate Alamar Blue Assay (MABA). The preliminary results showed that compounds 4e, 4d and 4g had 87%, 93% and 92% inhibitory effect respectively.
Similar content being viewed by others
References
H.S. Gold, R.C. Moellering, N. Engl. J. Med. 335 (1996) 1445.
R.P. Tripati, N. Tewari, N. Dwivedi, V.K. Tiwari, Med. Res. Rev. 25 (2005) 93.
K.G. Desai, J. P. Raval, K.R. Desai, J. Iranian Chem. Soc. 3 (2006) 233.
A.F.A. Harb, H.H. Abbas, F.H. Motafa, J. Iranian Chem. Soc. 2 (2005) 115.
L.N. Jungheim, S.K. Sigmund, N.D. Jones, J.K. Swartzend, Tet. Lett. 28 (1990) 285.
N.E. Allen, J.N. Hobbs, D.A. Preston, J.R. Turner, J. Antibiot. 23 (1990) 92.
A.A. Bilgin, E. Palaska, R. Sunal, B. Gumusel, Pharmazie 49 (1994) 67.
N. Gokhan, A. Yesilada, G. Ucar, K. Erol, A.A. Bilgin, Arch. Pharm. 336 (2003) 362.
M.S. Shingar, B.H. Siddiqui, Arzneimittelforschung. 338 (2006) 96.
F. Chimenti, B. Bizzarri, F. Manna, A. Bolasco, D. Secci, Chimenti, P. Granese, A. Scaltrito, Bioorg. Med. Chem. Lett. 15 (2005) 603.
R. Soliman, N.S. Habib, F.A. Ashour, M. el-Taiebi, Bollettino Chimico Farmaceutico 140 (2001)140.
E. Palaska, M. Aytemir, T.I. Uzbay, D. Erol, Eur. J. Med. Chem. 36 (2001) 539.
S. Guinzkucukguzel, S. Rollas, Il Farmaco 35 (2002) 761.
A.A. Bekhit, H.M.A. Ashour, A.A. Guemei, Arch. Pharm. 338 (2005) 167.
M. Bagheri, M. Shekarchi, M. Jorjani, M.H. Ghahremani, M. A. Shafiee, Arch. Pharm. 337 (2004) 25.
E.J. Baron, S.M. Finegolg, in: Bailey and Scott’s Diagnostic Microbiology. C.V. Mosby, St Louis, 1990, pp. 184–188.
A.A. Bilgin, E. Palaska, R. Sunal, Arzneimittelforschung 43 (1993) 1041.
R.H. Wiley, C.H. Jarboe, F.V. Hayes, E. hansbury, J.T. Nielsen, P.X. Callahan, M.C. Sellars, J. Org. Chem. 23 (1958) 732.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shekarchi, M., Pirali-Hamedani, M., Navidpour, L. et al. Synthesis, antibacterial and antifungal activities of 3-aryl-5-(pyridin-3-yl)-4,5-dihydropyrazole-1-carbothioamide derivatives. JICS 5, 150–158 (2008). https://doi.org/10.1007/BF03245828
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03245828